Suppr超能文献

糖皮质激素对中性粒细胞计数的影响:一项住院患者队列研究。

Effects of glucocorticoids on the neutrophil count: a cohort study among hospitalized patients.

机构信息

Faculty of Science, Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute of Pharmaceutical Sciences, Utrecht University, P.O. Box 80082, 3508 TB Utrecht, The Netherlands.

出版信息

Pulm Pharmacol Ther. 2010 Apr;23(2):129-34. doi: 10.1016/j.pupt.2009.10.006. Epub 2009 Oct 29.

Abstract

BACKGROUND

Systemic glucocorticoids are often used in clinical practice for a large variety of indications. Clinical observations have shown that patients using glucocorticoids often have higher neutrophil counts. Debate remains whether this observed neutrophilia is associated with glucocorticoid use or that other factors, like disease and severity of disease, should be considered. The objective of this study was to investigate the effect of systemic glucocorticoids on the absolute neutrophil count in hospitalized patients.

METHODS

A cohort study was conducted using data from the Utrecht Patient Oriented Database which comprises clinical data of patients of the University Medical Center Utrecht. We identified all adult patients, hospitalized in 2005 with at least two blood samples for hematological testing during admission and compared in-hospital glucocorticoid use with non-use.

RESULTS

A total of 809 glucocorticoid users and 2658 non-users were included in the study with comparable neutrophil counts at admission (8.2.10(9)/l for glucocorticoid users and 8.0.10(9)/l for non-users). Overall analysis showed a slight association between glucocorticoid use and an increase in neutrophil count (RR 1.3; 95% CI 1.1-1.5). However, within diagnostic subgroups there was no increase in neutrophil count in glucocorticoid users. Furthermore, among all no dose response relationship, no effect of time between the two samples, and no effect of anti-inflammatory/sodium retaining potency was found.

CONCLUSION

Observed neutrophilia in users of systemic glucocorticoids is probably associated with underlying disease, rather than glucocorticoid use itself.

摘要

背景

临床上常将全身性糖皮质激素用于多种适应证。临床观察显示,使用糖皮质激素的患者中性粒细胞计数往往较高。目前仍存在争议,即这种观察到的中性粒细胞增多是否与糖皮质激素的使用有关,或者其他因素,如疾病和疾病严重程度,应被视为相关因素。本研究旨在探讨全身性糖皮质激素对住院患者绝对中性粒细胞计数的影响。

方法

本研究采用乌得勒支患者导向数据库的数据进行队列研究,该数据库包含乌得勒支大学医学中心患者的临床数据。我们确定了所有在 2005 年住院的成年患者,他们在住院期间至少有两次血液样本用于血液学检测,并比较了住院期间糖皮质激素的使用情况和非使用情况。

结果

共纳入 809 例糖皮质激素使用者和 2658 例非使用者,两组患者入院时的中性粒细胞计数相当(糖皮质激素使用者为 8.2.10(9)/l,非使用者为 8.0.10(9)/l)。总体分析显示,糖皮质激素的使用与中性粒细胞计数的轻度增加之间存在一定的相关性(RR 1.3;95%CI 1.1-1.5)。然而,在诊断亚组中,糖皮质激素使用者的中性粒细胞计数并没有增加。此外,在所有情况下均未发现剂量反应关系、两次采样之间的时间效应以及抗炎/保钠效力的效应。

结论

观察到使用全身性糖皮质激素的患者中性粒细胞增多可能与基础疾病有关,而不是糖皮质激素的使用本身。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验